Here is What Hedge Funds Think About Apogee Enterprises, Inc. (APOG)

Page 1 of 2

Should Apogee Enterprises, Inc. (NASDAQ:APOG) investors track the following data?

If you were to ask many market players, hedge funds are perceived as delayed, old investment vehicles of a period lost to current times. Although there are In excess of 8,000 hedge funds in operation currently, Insider Monkey looks at the bigwigs of this club, about 525 funds. It is assumed that this group oversees most of all hedge funds’ total assets, and by paying attention to their highest performing investments, we’ve determined a few investment strategies that have historically outpaced the market. Our small-cap hedge fund strategy outpaced the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outpaced the S&P 500 index by 33 percentage points in 11 months (find a sample of our picks).

Apogee Enterprises, Inc. (NASDAQ:APOG)

Just as useful, optimistic insider trading sentiment is a second way to analyze the world of equities. As the old adage goes: there are a variety of reasons for a corporate insider to get rid of shares of his or her company, but just one, very simple reason why they would initiate a purchase. Plenty of academic studies have demonstrated the market-beating potential of this strategy if investors understand where to look (learn more here).

Thus, it’s important to study the latest info about Apogee Enterprises, Inc. (NASDAQ:APOG).

Hedge fund activity in Apogee Enterprises, Inc. (NASDAQ:APOG)

At Q2′s end, a total of 11 of the hedge funds we track held long positions in this stock, a change of 10% from the first quarter. With hedgies’ capital changing hands, there exists a select group of key hedge fund managers who were increasing their holdings considerably.

Out of the hedge funds we follow, Royce & Associates, managed by Chuck Royce, holds the biggest position in Apogee Enterprises, Inc. (NASDAQ:APOG). Royce & Associates has a $33.3 million position in the stock, comprising 0.1% of its 13F portfolio. On Royce & Associates’s heels is Renaissance Technologies, managed by Jim Simons, which held a $6.4 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Some other hedgies with similar optimism include Cliff Asness’s AQR Capital Management, Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners and Richard Driehaus’s Driehaus Capital.

As one would understandably expect, specific money managers were leading the bulls’ herd. Royce & Associates, managed by Chuck Royce, established the largest position in Apogee Enterprises, Inc. (NASDAQ:APOG). Royce & Associates had 33.3 million invested in the company at the end of the quarter. Jim Simons’s Renaissance Technologies also initiated a $6.4 million position during the quarter. The other funds with brand new APOG positions are Cliff Asness’s AQR Capital Management, Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners, and Richard Driehaus’s Driehaus Capital.

What have insiders been doing with Apogee Enterprises, Inc. (NASDAQ:APOG)?

Bullish insider trading is at its handiest when the company in focus has experienced transactions within the past six months. Over the last 180-day time period, Apogee Enterprises, Inc. (NASDAQ:APOG) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to Apogee Enterprises, Inc. (NASDAQ:APOG). These stocks are AAON, Inc. (NASDAQ:AAON), Griffon Corporation (NYSE:GFF), Universal Forest Products, Inc. (NASDAQ:UFPI), Headwaters Inc (NYSE:HW), and Trex Company, Inc. (NYSE:TREX). This group of stocks are the members of the general building materials industry and their market caps match APOG’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!